(no title)
deugtniet | 2 years ago
Regarding your 'low-impact' comment I have a few thoughts. 1. Although this is a large study, they do not find any world shocking new insights that are otherwise found in other studies. Cholesterol phenotypes are very well studied. Changing a guideline is usually not done based on a study of a single population. 2. They do not account for medication usage which confounds results. 3. They do not find a causal relationship between cholesterol and mortality, only provide an association.
No comments yet.